Literature DB >> 16477906

Toxoplasmosis during pregnancy.

Ariel Many1, Gideon Koren.   

Abstract

QUESTION: One of my female patients was tested for Toxoplasma and found positive for immunoglobulin G (IgG). She is planning to get pregnant soon. What are the risks for her and her baby? ANSWER: Up to 25% of Canadians are IgG-positive for Toxoplasma due to past exposure. Immunoglobulin M (IgM) titres indicate current infection. Toxoplasma gondii is an obligate intracellular protozoan that has several forms during its life cycle: oocyte, tachyzoite, and cyst.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16477906      PMCID： PMC1479740     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  12 in total

Review 1.  ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. (Replaces educational bulletin number 177, February 1993). American College of Obstetrics and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2002-01       Impact factor: 3.561

2.  Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team.

Authors:  W R Bowie; A S King; D H Werker; J L Isaac-Renton; A Bell; S B Eng; S A Marion
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

3.  Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.

Authors:  D Dunn; M Wallon; F Peyron; E Petersen; C Peckham; R Gilbert
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

4.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

5.  Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group.

Authors:  M Wilson; J S Remington; C Clavet; G Varney; C Press; D Ware
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.

Authors:  R Gilbert; L Gras
Journal:  BJOG       Date:  2003-02       Impact factor: 6.531

7.  Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

Authors:  W Foulon; I Villena; B Stray-Pedersen; A Decoster; M Lappalainen; J M Pinon; P A Jenum; K Hedman; A Naessens
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

8.  Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid.

Authors:  P Hohlfeld; F Daffos; J M Costa; P Thulliez; F Forestier; M Vidaud
Journal:  N Engl J Med       Date:  1994-09-15       Impact factor: 91.245

9.  Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.

Authors:  W Foulon; A Naessens; S Lauwers; F De Meuter; J J Amy
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

10.  Seroprevalence of Toxoplasma gondii infection among veterinary staff in Ontario, Canada (2002): implications for teratogenic risk.

Authors:  Samar Shuhaiber; Gideon Koren; Rada Boskovic; Thomas R Einarson; Offie Porat Soldin; Adrienne Einarson
Journal:  BMC Infect Dis       Date:  2003-05-23       Impact factor: 3.090
View more
  5 in total

1.  Diagnosis of acute toxoplasmosis by IgG avidity method in pregnant women referred to health centers in south-eastern Iran.

Authors:  Mansour Rahmati-Balaghaleh; Bibi Razieh Hosseini Farash; Mehdi Zarean; Saeed Hatami-Pourdehno; Hadi Mirahmadi; Lida Jarahi; Yousef Sharifi; Omid Ahmadi; Seyed Aliakbar Shamsian; Elham Moghaddas; Seyed Mohammad Hashemi Shahri
Journal:  J Parasit Dis       Date:  2019-05-03

2.  Prevalence and genotyping ofToxoplasma gondii among Saudi pregnant women in Saudi Arabia.

Authors:  Jawahir Alghamdi; Maha Hussein Elamin; Samia Alhabib
Journal:  Saudi Pharm J       Date:  2015-05-23       Impact factor: 4.330

3.  Seroprevalence of Gestational and Neonatal Toxoplasmosis as well as Risk Factors in Yaoundé, Cameroon.

Authors:  Joy Nkain Ayeah; Adesina Oladokun; Irene Ule Ngole Sumbele; Abiodun Olatunbosun Ilesanmi; Obase Ngemani Bekindaka
Journal:  J Parasitol Res       Date:  2022-03-21

4.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

5.  Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.

Authors:  Abdulelah H Al-Adhroey; Amat Al-Khaleq O Mehrass; Abdulqawi A Al-Shammakh; Abdullatif D Ali; Mohammed Y M Akabat; Hesham M Al-Mekhlafi
Journal:  BMC Infect Dis       Date:  2019-12-30       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.